Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
The characteristic of cardiorenal syndrome (CRS) is simultaneous damage to both the heart and kidneys. CRS has caused a heavy burden of mortality and incidence rates worldwide. The regulation of host microbiota metabolism that triggers heart and kidney damage is an emerging research field that promo...
Saved in:
| Main Authors: | Yuchen Lai, Yujie Zhu, Xihui Zhang, Shifang Ding, Fang Wang, Jincen Hao, Zhaomeng Wang, Congqi Shi, Yongjin Xu, Lemin Zheng, Wei Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000970 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases
by: Wan Chen, et al.
Published: (2025-07-01) -
CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
by: E. A. Medvedeva, et al.
Published: (2017-02-01) -
Gut Microbiota-Derived Metabolites and Their Role in the Pathogenesis of Necrotizing Enterocolitis in Preterm Infants: A Narrative Review
by: Livia Provitera, et al.
Published: (2024-10-01) -
RENAL ARTERIES REMODELLING — THE INITIATOR AND TARGET OF CARDIORENAL CONTINUUM
by: T. S. Levitskaya, et al.
Published: (2015-02-01) -
Hyperuricemia and adverse outcomes in patients with cardiorenal syndrome: A nationwide prospective cohort study in China
by: Zhanyuan Chen, et al.
Published: (2025-06-01)